Interestingly, Strawbridge et al. demonstrated the function of soluble CD93 (sCD93) in glucometabolic regulation, and lower sCD93 levels might be related to type 2 diabetes patients who have a higher cardiovascular disease risk [38]. This evidence concerns the gene CD93 and type 2 diabetes mellitus.